chr1-230690156-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_007357.3(COG2):c.1934+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000122 in 1,610,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007357.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COG2 | NM_007357.3 | c.1934+3A>G | splice_region_variant, intron_variant | ENST00000366669.9 | NP_031383.1 | |||
COG2 | NM_001145036.2 | c.1931+3A>G | splice_region_variant, intron_variant | NP_001138508.1 | ||||
COG2 | XM_047449445.1 | c.1595+3A>G | splice_region_variant, intron_variant | XP_047305401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COG2 | ENST00000366669.9 | c.1934+3A>G | splice_region_variant, intron_variant | 1 | NM_007357.3 | ENSP00000355629.4 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000244 AC: 6AN: 246292Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133150
GnomAD4 exome AF: 0.000131 AC: 191AN: 1458568Hom.: 0 Cov.: 30 AF XY: 0.000125 AC XY: 91AN XY: 725580
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74390
ClinVar
Submissions by phenotype
Congenital disorder of glycosylation, type IIq Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 17, 2018 | This sequence change falls in intron 16 of the COG2 gene. It does not directly change the encoded amino acid sequence of the COG2 protein, but it affects a nucleotide within the consensus splice site of the intron. This variant is present in population databases (rs368077748, ExAC 0.01%). This variant has not been reported in the literature in individuals with COG2-related disease. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at